Cargando…
Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis
BACKGROUND: Clinically significant portal hypertension (CSPH) and severe portal hypertension (SPH) increase the risk for decompensation and life-threatening complications in liver cirrhosis. Pathologic angiogenesis might contribute to the formation of these conditions. Placental growth factor (PlGF)...
Autores principales: | Gelman, Sigita, Salteniene, Violeta, Pranculis, Andrius, Skieceviciene, Jurgita, Zykus, Romanas, Petrauskas, Dalius, Kupcinskas, Limas, Canbay, Ali, Link, Alexander, Kupcinskas, Juozas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589742/ https://www.ncbi.nlm.nih.gov/pubmed/31249451 http://dx.doi.org/10.3748/wjg.v25.i23.2935 |
Ejemplares similares
-
Endogenous motion of liver correlates to the severity of portal hypertension
por: Gelman, Sigita, et al.
Publicado: (2020) -
Circulating microbiome in patients with portal hypertension
por: Gedgaudas, Rolandas, et al.
Publicado: (2022) -
Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study
por: Zykus, Romanas, et al.
Publicado: (2015) -
Erratum to: Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study
por: Zykus, Romanas, et al.
Publicado: (2016) -
Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer
por: Petkevicius, Vytenis, et al.
Publicado: (2017)